ClinicalTrials.Veeva

Menu

Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair

The University of Texas System (UT) logo

The University of Texas System (UT)

Status and phase

Completed
Phase 2
Phase 1

Conditions

Cleft Palate
Cleft Lip
Scarring

Treatments

Drug: Normal Saline Injection
Drug: Botulinum Toxin Type A

Study type

Interventional

Funder types

Other

Identifiers

NCT02247193
HSC-MS-14-0335

Details and patient eligibility

About

Objective: To determine if the use of botulinum toxin during primary cleft lip repair improves the cosmetic appearance of the cleft lip scar

Enrollment

30 patients

Sex

All

Ages

Under 6 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • complete unilateral cleft lip with or without cleft palate
  • planned for a primary cleft lip repair

Exclusion criteria

-bilateral cleft lip

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

30 participants in 2 patient groups, including a placebo group

Botulinum Toxin
Experimental group
Description:
Injection of botulinum toxin into cleft lip at time of surgical repair.
Treatment:
Drug: Botulinum Toxin Type A
Saline
Placebo Comparator group
Description:
Injection of normal saline into cleft lip at time of surgical repair.
Treatment:
Drug: Normal Saline Injection

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems